Literature DB >> 9562375

Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection.

J Vingerhoets1, E Bisalinkumi, G Penne, R Colebunders, E Bosmans, L Kestens, G Vanham.   

Abstract

A dysregulated production of regulatory cytokines has been proposed as a determinant in the progression of HIV infection. The sensitivity of T-cells to these cytokines has, however, not fully been investigated. Therefore, the responses of PBMC and T-cell subsets to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV-infected patients and HIV-negative controls were compared by examining their effect on the production of secondary cytokines (IFNgamma, IL-4 and IL-10), by simultaneous determination of T-cell activation and apoptosis and by measuring cytokine receptor expression. Production of IFNgamma was decreased in PBMC from the patients after stimulation with several combinations of stimulatory cytokines. IL-10 was only induced upon stimulation with IL-2 and IL-12 and tended to be produced more in patients. Expression of the different cytokine receptor chains showed complex alterations in HIV+ patients as compared to controls. The most pronounced changes were decreased expression of both IL-2Ralpha and IL-7Ralpha chain on CD8+ T-cells and an increase of IL-12Rbeta on both T-cell subsets from the patients. Evaluation of CD25 upregulation and blast formation revealed a deficient response to all three stimulatory cytokines in CD8+ but not in CD4+ T-cells from patients as compared to controls. Both CD4+ and CD8+ T-cells from the patients were less sensitive to the anti-apoptotic effect of IL-7 whereas only CD8+ T-cells were less sensitive to the anti-apoptotic effect of IL-2. The present data show that CD8+ T-cells, and to a lesser extent CD4+ T-cells, become less sensitive to IL-2, IL-7 and IL-12 during HIV infection. The decreased capacity of T-cells to respond to these cytokines could contribute to the HIV-related immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562375     DOI: 10.1016/s0165-2478(97)00162-4

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  16 in total

1.  Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.

Authors:  E C Darcissac; V Vidal; X De La Tribonniere; Y Mouton; G M Bahr
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Effects of lymphocyte isolation and timing of processing on detection of CD127 expression on T cells in human immunodeficiency virus-infected patients.

Authors:  Jeanette Higgins; Julia A Metcalf; Randy A Stevens; Michael Baseler; Martha C Nason; H Clifford Lane; Irini Sereti
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infection.

Authors:  Alison M O'Connor; Angela M Crawley; Jonathan B Angel
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

4.  Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Authors:  Y Xiong; M A Luscher; J D Altman; M Hulsey; H L Robinson; M Ostrowski; B H Barber; K S MacDonald
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals.

Authors:  Lia Vassena; Michael Proschan; Anthony S Fauci; Paolo Lusso
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

Review 6.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

7.  Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway.

Authors:  Olivier Juffroy; Florence Bugault; Olivier Lambotte; Ivan Landires; Jean-Paul Viard; Loïc Niel; Arnaud Fontanet; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

8.  CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART).

Authors:  J-H Colle; J-L Moreau; A Fontanet; O Lambotte; M Joussemet; J-F Delfraissy; J Thèze
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

9.  Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.

Authors:  Jose F Camargo; Hemant Kulkarni; Brian K Agan; Alvaro A Gaitan; Lisa A Beachy; Sowmya Srinivas; Weijing He; Stephanie Anderson; Vincent C Marconi; Matthew J Dolan; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

10.  Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma.

Authors:  Sylvie Faucher; Angela M Crawley; Wendy Decker; Alice Sherring; Dragica Bogdanovic; Tao Ding; Michele Bergeron; Jonathan B Angel; Paul Sandstrom
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.